HomeCompareASDRF vs JNJ

ASDRF vs JNJ: Dividend Comparison 2026

ASDRF yields 4000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASDRF wins by $7175340620755.85M in total portfolio value
10 years
ASDRF
ASDRF
● Live price
4000.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7175340620755.87M
Annual income
$6,839,006,593,197,835,000.00
Full ASDRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ASDRF vs JNJ

📍 ASDRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASDRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASDRF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASDRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASDRF
Annual income on $10K today (after 15% tax)
$340,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,813,155,604,218,160,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ASDRF beats the other by $5,813,155,604,218,159,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASDRF + JNJ for your $10,000?

ASDRF: 50%JNJ: 50%
100% JNJ50/50100% ASDRF
Portfolio after 10yr
$3587670310377.95M
Annual income
$3,419,503,296,598,918,000.00/yr
Blended yield
95.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ASDRF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-6.2
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASDRF buys
0
JNJ buys
0
No recent congressional trades found for ASDRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASDRFJNJ
Forward yield4000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$7175340620755.87M$20.0K
Annual income after 10y$6,839,006,593,197,835,000.00$827.78
Total dividends collected$7152397773804.84M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: ASDRF vs JNJ ($10,000, DRIP)

YearASDRF PortfolioASDRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$410,700$400,000.00$10,676$355.77+$400.0KASDRF
2$15,792,720$15,353,271.03$11,407$389.39+$15.78MASDRF
3$568,657,142$551,758,931.89$12,198$426.53+$568.64MASDRF
4$19,176,207,860$18,567,744,718.20$13,056$467.62+$19176.19MASDRF
5$605,696,028,890$585,177,486,479.73$13,987$513.12+$605696.01MASDRF
6$17,922,210,653,594$17,274,115,902,681.27$14,998$563.56+$17922210.64MASDRF
7$496,869,793,504,300$477,693,028,104,954.00$16,098$619.52+$496869793.49MASDRF
8$12,908,672,105,251,704$12,377,021,426,202,104.00$17,295$681.69+$12908672105.23MASDRF
9$314,330,866,876,668,540$300,518,587,724,049,200.00$18,599$750.82+$314330866876.65MASDRF
10$7,175,340,620,755,871,000$6,839,006,593,197,835,000.00$20,022$827.78+$7175340620755.85MASDRF

ASDRF vs JNJ: Complete Analysis 2026

ASDRFStock

Ascendant Resources Inc., a mining company, explores for and develops mineral properties. The company explores for zinc, copper, lead, tin, silver, gold, and other metals. It holds 50% interest in the Lagoa Salgada volcanogenic massive sulphide project, which covers an area of 10,700 hectares located on the Iberian Pyrite Belt in Portugal. The company was formerly known as Morumbi Resources Inc. and changed its name to Ascendant Resources Inc. in December 2016. Ascendant Resources Inc. was incorporated in 2006 and is headquartered in Toronto, Canada.

Full ASDRF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ASDRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASDRF vs SCHDASDRF vs JEPIASDRF vs OASDRF vs KOASDRF vs MAINASDRF vs ABBVASDRF vs MRKASDRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.